M. Wachsman

1.0k total citations
19 papers, 783 citations indexed

About

M. Wachsman is a scholar working on Epidemiology, Virology and Oncology. According to data from OpenAlex, M. Wachsman has authored 19 papers receiving a total of 783 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Epidemiology, 4 papers in Virology and 4 papers in Oncology. Recurrent topics in M. Wachsman's work include Herpesvirus Infections and Treatments (12 papers), Cytomegalovirus and herpesvirus research (6 papers) and Virus-based gene therapy research (4 papers). M. Wachsman is often cited by papers focused on Herpesvirus Infections and Treatments (12 papers), Cytomegalovirus and herpesvirus research (6 papers) and Virus-based gene therapy research (4 papers). M. Wachsman collaborates with scholars based in United States and Argentina. M. Wachsman's co-authors include Brent G. Petty, Laure Aurelian, Vinay Chaudhry, Stephen J. Peroutka, Dominick Sinicropi, David R. Cornblath, Louis E. Burton, Bruce T. Adornato, Charles Flexner and Paul S. Lietman and has published in prestigious journals such as Clinical Infectious Diseases, Annals of Neurology and The Journal of Infectious Diseases.

In The Last Decade

M. Wachsman

19 papers receiving 749 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M. Wachsman United States 13 302 205 193 127 113 19 783
M C Graves United States 18 180 0.6× 278 1.4× 203 1.1× 66 0.5× 302 2.7× 26 1.1k
N. Sauze France 19 226 0.7× 84 0.4× 123 0.6× 69 0.5× 166 1.5× 36 906
L. Belbeck Canada 16 118 0.4× 204 1.0× 154 0.8× 89 0.7× 281 2.5× 32 1.1k
Angela Siegling Germany 13 121 0.4× 93 0.5× 131 0.7× 62 0.5× 133 1.2× 21 730
Alfons Van Lommel Belgium 23 231 0.8× 468 2.3× 420 2.2× 124 1.0× 486 4.3× 45 1.7k
Adalbert Koestner United States 19 319 1.1× 157 0.8× 56 0.3× 70 0.6× 217 1.9× 46 953
Geraldina Dominguez United States 14 480 1.6× 113 0.6× 235 1.2× 224 1.8× 159 1.4× 15 980
C A Noonan United States 16 420 1.4× 148 0.7× 177 0.9× 163 1.3× 255 2.3× 20 1.5k
Micheline McCarthy United States 20 454 1.5× 84 0.4× 97 0.5× 117 0.9× 252 2.2× 49 1.2k
Maya Desai United Kingdom 17 194 0.6× 153 0.7× 312 1.6× 39 0.3× 308 2.7× 32 1.3k

Countries citing papers authored by M. Wachsman

Since Specialization
Citations

This map shows the geographic impact of M. Wachsman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Wachsman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Wachsman more than expected).

Fields of papers citing papers by M. Wachsman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Wachsman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Wachsman. The network helps show where M. Wachsman may publish in the future.

Co-authorship network of co-authors of M. Wachsman

This figure shows the co-authorship network connecting the top 25 collaborators of M. Wachsman. A scholar is included among the top collaborators of M. Wachsman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Wachsman. M. Wachsman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Wales, Samantha Q., Cynthia C. Smith, M. Wachsman, Gary J. Calton, & Laure Aurelian. (2004). Performance and Use of a Ribonucleotide Reductase Herpes Simplex Virus Type-Specific Serological Assay. Clinical and Vaccine Immunology. 11(1). 42–49. 4 indexed citations
2.
Wachsman, M., Michael Kulka, Cynthia C. Smith, & Laure Aurelian. (2001). A growth and latency compromised herpes simplex virus type 2 mutant (ICP10ΔPK) has prophylactic and therapeutic protective activity in guinea pigs. Vaccine. 19(15-16). 1879–1890. 34 indexed citations
3.
Wachsman, M., C. Harold Mielke, John A. Hayes, & Danial E. Baker. (2000). The Use of Time Step Simulations and Difference Equations (TSSADEQ) in Modeling Heparin Pharmacokinetics. The Journal of Clinical Pharmacology. 40(10). 1121–1128. 1 indexed citations
4.
Mestre, M, et al.. (1999). [Importance of the choice and monitoring of culture systems and developments in the diagnosis of infection by Chlamydia].. PubMed. 31 Suppl 1. 21–3. 1 indexed citations
5.
Wachsman, M., Brent G. Petty, K C Cundy, et al.. (1996). Pharmacokinetics, safety and bioavailability of HPMPC (cidofovir) in human immunodeficiency virus-infected subjects. Antiviral Research. 29(2-3). 153–161. 73 indexed citations
6.
Wachsman, M., Fayez M. Hamzeh, Hirohisa Saito, & Paul S. Lietman. (1996). Anticytomegaloviral activity of methotrexate associated with preferential accumulation of drug by cytomegalovirus-infected cells. Antimicrobial Agents and Chemotherapy. 40(2). 433–436. 8 indexed citations
7.
Wachsman, M., et al.. (1996). Antiviral Activity of Inhibitors of Pyrimidine De-Novo Biosynthesis. Antiviral chemistry & chemotherapy. 7(1). 7–13. 13 indexed citations
8.
Cundy, K C, Brent G. Petty, John F. Flaherty, et al.. (1995). Clinical pharmacokinetics of cidofovir in human immunodeficiency virus-infected patients. Antimicrobial Agents and Chemotherapy. 39(6). 1247–1252. 141 indexed citations
9.
Petty, Brent G., David R. Cornblath, Bruce T. Adornato, et al.. (1994). The effect of systemically administered recombinant human nerve growth factor in healthy human subjects. Annals of Neurology. 36(2). 244–246. 318 indexed citations
10.
Kulka, Michael, M. Wachsman, Shunsuke Miura, et al.. (1993). Antiviral effect of oligo(nucleoside methylphosphonates) complementary to the herpes simplex virus type 1 immediate early mRNAs 4 and 5. Antiviral Research. 20(2). 115–130. 33 indexed citations
11.
12.
Aurelian, Laure, Cynthia C. Smith, M. Wachsman, & Enzo Paoletti. (1991). Immune Responses to Herpes Simplex Virus in Guinea Pigs (Footpad Model) and Mice Immunized with Vaccinia Virus Recombinants Containing Herpes Simplex Virus Glycoprotein D. Clinical Infectious Diseases. 13(Supplement_11). S924–S934. 18 indexed citations
13.
Wachsman, M., Laure Aurelian, & Joseph W. Burnett. (1991). Human immunosuppression induced by sea nettle (Chrysaora quinquecirrha) venom. Toxicon. 29(3). 386–390. 4 indexed citations
14.
Wachsman, M., Laure Aurelian, & Joseph W. Burnett. (1990). The prophylactic use of cyclooxygenase inhibitors in recurrent herpes simplex infections. British Journal of Dermatology. 123(3). 375–380. 20 indexed citations
15.
16.
Wachsman, M., Laure Aurelian, Cynthia C. Smith, Marion E. Perkus, & Enzo Paoletti. (1989). Regulation of Expression of Herpes Simplex Virus (HSV) Glycoprotein D in Vaccinia Recombinants Affects Their Ability to Protect from Cutaneous HSV-2 Disease. The Journal of Infectious Diseases. 159(4). 625–634. 15 indexed citations
17.
18.
19.
Wachsman, M., Laure Aurelian, Cynthia C. Smith, et al.. (1987). Protection of Guinea Pigs from Primary and Recurrent Herpes Simplex Virus (HSV) Type 2 Cutaneous Disease with Vaccinia Virus Recombinants Expressing HSV Glycoprotein D. The Journal of Infectious Diseases. 155(6). 1188–1197. 47 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by M C Graves Breakdown of academic impact, for papers by N. Sauze Breakdown of academic impact, for papers by L. Belbeck Breakdown of academic impact, for papers by Angela Siegling Breakdown of academic impact, for papers by Alfons Van Lommel Breakdown of academic impact, for papers by Adalbert Koestner Breakdown of academic impact, for papers by Geraldina Dominguez Breakdown of academic impact, for papers by C A Noonan Breakdown of academic impact, for papers by Micheline McCarthy Breakdown of academic impact, for papers by Maya Desai
Rankless by CCL
2026